Free Trial
NASDAQ:CDIO

Cardio Diagnostics (CDIO) Stock Price, News & Analysis

Cardio Diagnostics logo
$0.36 +0.03 (+9.09%)
Closing price 04/1/2025 04:00 PM Eastern
Extended Trading
$0.35 -0.01 (-2.78%)
As of 08:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cardio Diagnostics Stock (NASDAQ:CDIO)

Key Stats

Today's Range
$0.33
$0.40
50-Day Range
$0.33
$0.68
52-Week Range
$0.19
$1.77
Volume
919,608 shs
Average Volume
2.52 million shs
Market Capitalization
$18.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Buy

Company Overview

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Remove Ads

Cardio Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

CDIO MarketRank™: 

Cardio Diagnostics scored higher than 56% of companies evaluated by MarketBeat, and ranked 467th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardio Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cardio Diagnostics has received no research coverage in the past 90 days.

  • Read more about Cardio Diagnostics' stock forecast and price target.
  • Percentage of Shares Shorted

    2.59% of the float of Cardio Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardio Diagnostics has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardio Diagnostics has recently decreased by 36.87%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cardio Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Cardio Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.59% of the float of Cardio Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardio Diagnostics has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardio Diagnostics has recently decreased by 36.87%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cardio Diagnostics has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cardio Diagnostics this week, compared to 0 articles on an average week.
  • Search Interest

    Only 5 people have searched for CDIO on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Cardio Diagnostics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.30% of the stock of Cardio Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.06% of the stock of Cardio Diagnostics is held by institutions.

  • Read more about Cardio Diagnostics' insider trading history.
Receive CDIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

CDIO Stock News Headlines

Cardio Diagnostics (CDIO) to Release Quarterly Earnings on Monday
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Cardio Diagnostics files $50M mixed securities shelf
9 AI Stocks Investors Are Monitoring
See More Headlines

CDIO Stock Analysis - Frequently Asked Questions

Cardio Diagnostics' stock was trading at $0.9170 at the start of the year. Since then, CDIO stock has decreased by 60.7% and is now trading at $0.36.
View the best growth stocks for 2025 here
.

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) released its earnings results on Monday, August, 12th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.07. The firm earned $0.01 million during the quarter, compared to analyst estimates of $0.13 million. Cardio Diagnostics had a negative trailing twelve-month return on equity of 258.85% and a negative net margin of 22,732.03%.

Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardio Diagnostics investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), MSP Recovery (LIFW), MSP Recovery (LIFW), NuCana (NCNA), Recursion Pharmaceuticals (RXRX) and SoundHound AI (SOUN).

Company Calendar

Last Earnings
8/12/2024
Today
4/02/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CDIO
Fax
N/A
Employees
1
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+455.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,380,000.00
Net Margins
-22,732.03%
Pretax Margin
-22,732.03%

Debt

Sales & Book Value

Annual Sales
$34,890.00
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
2.57

Miscellaneous

Free Float
40,517,000
Market Cap
$18.77 million
Optionable
Not Optionable
Beta
3.61
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CDIO) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners